216 related articles for article (PubMed ID: 29524585)
1. Mining the tree of life: Host defense peptides as antiviral therapeutics.
Shartouny JR; Jacob J
Semin Cell Dev Biol; 2019 Apr; 88():147-155. PubMed ID: 29524585
[TBL] [Abstract][Full Text] [Related]
2. [Viruses and antiviral drug resistance].
Hovi T; Järvinen A; Pyhälä R; Ristola M; Salminen M
Duodecim; 2002; 118(9):911-8. PubMed ID: 12238169
[No Abstract] [Full Text] [Related]
3. Intervention strategies for emerging viruses: use of antivirals.
Debing Y; Jochmans D; Neyts J
Curr Opin Virol; 2013 Apr; 3(2):217-24. PubMed ID: 23562753
[TBL] [Abstract][Full Text] [Related]
4. Human Antimicrobial Peptides as Therapeutics for Viral Infections.
Ahmed A; Siman-Tov G; Hall G; Bhalla N; Narayanan A
Viruses; 2019 Aug; 11(8):. PubMed ID: 31374901
[TBL] [Abstract][Full Text] [Related]
5. A review of the antiviral activity of cationic antimicrobial peptides.
Urmi UL; Vijay AK; Kuppusamy R; Islam S; Willcox MDP
Peptides; 2023 Aug; 166():171024. PubMed ID: 37172781
[TBL] [Abstract][Full Text] [Related]
6. Antiviral activity of Arthrospira-derived spirulan-like substances.
Rechter S; König T; Auerochs S; Thulke S; Walter H; Dörnenburg H; Walter C; Marschall M
Antiviral Res; 2006 Dec; 72(3):197-206. PubMed ID: 16884788
[TBL] [Abstract][Full Text] [Related]
7. Cationic host defence peptides: potential as antiviral therapeutics.
Gwyer Findlay E; Currie SM; Davidson DJ
BioDrugs; 2013 Oct; 27(5):479-93. PubMed ID: 23649937
[TBL] [Abstract][Full Text] [Related]
8. Cationic host defense peptides; novel antimicrobial therapeutics against Category A pathogens and emerging infections.
Findlay F; Proudfoot L; Stevens C; Barlow PG
Pathog Glob Health; 2016; 110(4-5):137-47. PubMed ID: 27315342
[TBL] [Abstract][Full Text] [Related]
9. Antiviral Activities of Human Host Defense Peptides.
Brice DC; Diamond G
Curr Med Chem; 2020; 27(9):1420-1443. PubMed ID: 31385762
[TBL] [Abstract][Full Text] [Related]
10. Basic biochemical and pharmacological aspects of antiviral agents.
Prusoff WH; Zucker M; Mancini WR; Otto MJ; Lin TS; Lee JJ
Antiviral Res; 1985; Suppl 1():1-10. PubMed ID: 3002248
[No Abstract] [Full Text] [Related]
11. The past, present and future of antiviral drug discovery.
Littler E
IDrugs; 2004 Dec; 7(12):1104-12. PubMed ID: 15599804
[TBL] [Abstract][Full Text] [Related]
12. Antiviral Activity of Myticin C Peptide from Mussel: an Ancient Defense against Herpesviruses.
Novoa B; Romero A; Álvarez ÁL; Moreira R; Pereiro P; Costa MM; Dios S; Estepa A; Parra F; Figueras A
J Virol; 2016 Sep; 90(17):7692-702. PubMed ID: 27307570
[TBL] [Abstract][Full Text] [Related]
13. Virus-Host Interactions: New Insights and Advances in Drug Development Against Viral Pathogens.
Prasad M; Ranjan K; Brar B; Shah I; Lalmbe U; Manimegalai J; Vashisht B; Gaury M; Kumar P; Khurana SK; Prasad G; Rawat J; Yadav V; Kumar S; Rao R
Curr Drug Metab; 2017; 18(10):942-970. PubMed ID: 28952435
[TBL] [Abstract][Full Text] [Related]
14. Editorial overview: Engineering for viral resistance.
von Brunn A
Curr Opin Virol; 2015 Oct; 14():v-vii. PubMed ID: 26320757
[No Abstract] [Full Text] [Related]
15. Broad-spectrum antivirals against viral fusion.
Vigant F; Santos NC; Lee B
Nat Rev Microbiol; 2015 Jul; 13(7):426-37. PubMed ID: 26075364
[TBL] [Abstract][Full Text] [Related]
16. Potential therapeutic application of host defense peptides.
Zhang L; Falla TJ
Methods Mol Biol; 2010; 618():303-27. PubMed ID: 20094872
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic manipulation of host cell death pathways to facilitate clearance of persistent viral infections.
Cooney J; Allison C; Preston S; Pellegrini M
J Leukoc Biol; 2018 Feb; 103(2):287-293. PubMed ID: 29345371
[TBL] [Abstract][Full Text] [Related]
18. Are Host Defense Peptides and Their Derivatives Ready to be Part of the Treatment of the Next Coronavirus Pandemic?
Rivas-Santiago B; Jacobo-Delgado Y; Rodriguez-Carlos A
Arch Immunol Ther Exp (Warsz); 2021 Sep; 69(1):25. PubMed ID: 34529143
[TBL] [Abstract][Full Text] [Related]
19. Toward the Discovery of Host-Defense Peptides in Plants.
Petre B
Front Immunol; 2020; 11():1825. PubMed ID: 32973760
[TBL] [Abstract][Full Text] [Related]
20. A new class of synthetic anti-lipopolysaccharide peptides inhibits influenza A virus replication by blocking cellular attachment.
Hoffmann J; Schneider C; Heinbockel L; Brandenburg K; Reimer R; Gabriel G
Antiviral Res; 2014 Apr; 104():23-33. PubMed ID: 24486207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
